Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 265

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

COVID-19 in children: the link in the transmission chain

Open access
Kelvin, Alyson A, Halperin, Scott · 2020 · The Lancet Infectious Diseases

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), emerged from Wuhan, Hubei province, China, in late 2019 and has now reached pandemic status. Coronaviruses typically cause mild upper respiratory tract infections; however, SARS-CoV-2, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) have all been associated with severe illness and death. Common symptoms reported in adults with COVID-19 are fever, dry cough, and fatigue; severe cases have been associated with dyspnoea and bilateral ground-glass opacities on chest CT. In China, the SARS-CoV-2 reproductive number is estimated at 2. The combined case-fatality rate is 2% in China, and the risk of death is increased significantly in older people (approximately 15%). It is noteworthy that infants and children have not been featured prominently in COVID-19 case statistics. An analysis from China has shown that children younger than 10 years account for only 1% of COVID-19 cases, similar to the proportion for SARS-CoV and MERS-CoV epidemics. Infants and young children are typically at high risk for admission to hospital after respiratory tract infection with viruses such as respiratory syncytial virus and influenza virus. Immaturity of the respiratory tract and immune system is thought to contribute to severe viral respiratory disease in this age group. Therefore, the absence of paediatric patients with COVID-19 has perplexed clinicians, epidemiologists, and scientists. Case definitions and management strategies for children are absent because of the limited number of paediatric patients with COVID-19. In The Lancet Infectious Diseases, Haiyan Qiu and colleagues have shed light on this under-represented population with a clinical report of 36 paediatric patients (aged 1–16 years) with PCRconfirmed COVID-19. Their analyses have important implications for clinical management of younger people with SARS-CoV-2 infection and social distancing policies to prevent virus transmission. The patients in this study were being treated at three hospitals located in Zhejiang province, China, which is 900 km from Wuhan. The children accounted for roughly 5% of total patients with COVID-19. Patients were stratified by disease severity and were assessed in hospital (mean duration of hospitalisation, 14 [SD 3] days) for secondary bacterial and fungal infection, sepsis, immune responses, and organ dysfunction (lung, liver, heart, and kidney). All children underwent CT examination for diagnosis of pneumonia. Ten (28%) patients were asymptomatic latent cases identified because either an adult family member had the infection or they had been exposed to the epidemic area. Contact tracing was also used to identify paediatric infections during the SARS-CoV and MERS-CoV epidemics. None of the children developed severe illness or died, similar to findings of SARS-CoV paediatric cases in 2002–03. The most commonly reported clinical finding in children with COVID-19 was pneumonia (19 [53%]); fever, dry cough, or both were the next most frequent symptoms. All children with COVID-19 were aggressively treated, which was also standard for children with SARS-CoV infection. Treatment for COVID-19 consisted of aerosolised interferon alfa in all children, lopinavir–ritonavir syrup twice a day for 14 days in 14 (39%), and supplemental oxygen for six (17%). Paediatric patients were discharged after two negative SARS-CoV-2 PCRs. Qiu and colleagues have done a very important preliminary study defining the clinical picture for children infected with SARS-CoV-2, which will be valued globally. Although this work will assist with case identification, management, and social policy guidance, much more information is needed to establish the optimum management regimen. Specifically, the data showed that paediatric patients with COVID-19 had mild or asymptomatic disease accompanied by pneumonia in about half the cases. It is unclear which children should be targeted for antiviral and immunomodulatory treatment, particularly in view of the high proportion of asymptomatic infected contacts. Together, these results could suggest that children have specific mechanisms regulating the interaction between the immune system and respiratory machinery, which could be contributing to milder disease. Possibly, lung infiltrates have a protective role during paediatric SARS-CoV-2 infection, similar to lymphocytes participating in inducible bronchus-associated lymphoid structure development after respiratory insult. Correlation between chest radiography and CT findings might give additional Lancet Infect Dis 2020

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(20)30236-x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 265

Metadata

Authors
Kelvin, A. A., & Halperin, S.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2020-06
Volume
20
Issue
6
Pages
633-634
ISSN
1473-3099 (ISSN-L)
OpenAlex
W3012810940
Cited by
265
References
8
FWCI
7.33
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COVID-19 in children: the link in the transmission chain. https://app.cochat.ai/papers/10.1016/s1473-3099(20)30236-x
The paper
Kelvin, A. A., & Halperin, S. (2020). COVID-19 in children: the link in the transmission chain. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(20)30236-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.